Natera, Inc. is a diagnostics company. The Company has molecular and bioinformatics technology that it deploys to change genetic diseases across the world. Its molecular assays measure various regions across the genome from samples as small as a single cell. Its statistical algorithms combine these measurements with the available data to detect a range of serious conditions. It is engaged in developing products for various oncology applications. In addition to its direct sales force in the United States, the Company has a global network of over 70 laboratory and distribution partners. It has introduced a cloud-based distribution model. It also has launched seven molecular diagnostic tests. The Company launched Panorama, which is its non-invasive prenatal test (NIPT). Its products include Pre-implantation Genetic Screening, Pre-implantation Genetic Diagnosis, Products of Conception, Non-Invasive Paternity Testing, High Throughput Carrier Screening and Non-Invasive Prenatal Testing.